Observational Study Evaluating Hospital-Based Chronic Disease Management Platform in Adults With Type 2 Diabetes

This retrospective observational study examined adults with type 2 diabetes mellitus enrolled in a hospital-based chronic disease management platform. The setting was the Guangdong Provincial Hospital of Traditional Chinese Medicine. Follow-up duration extended up to 36 months. The sample size was not reported. The study focused on glycated hemoglobin changes.

The intervention involved the hospital-based chronic disease management platform. There was no reported comparator. The primary outcomes included longitudinal changes in glycated hemoglobin and HbA1c target attainment. Secondary outcomes were not reported. Medication details were not reported.

Specific numerical results regarding glycated hemoglobin changes or target attainment rates were not reported in the provided data. Consequently, the magnitude of effect cannot be quantified. The study did not provide specific data points for analysis. No statistical comparisons were available.

Safety data, including adverse events, serious adverse events, and discontinuations, were not reported. A key limitation is the lack of long-term real-world evidence on diabetes management platforms in Traditional Chinese Medicine hospitals. The observational study design limits causal inference. Generalizability to other settings is uncertain.

Practice relevance was not reported. Clinicians should interpret these findings cautiously given the absence of specific efficacy data and safety reporting. Further research is needed to establish clinical utility. Current evidence is insufficient for practice changes.